An emphasis on the interaction of signaling pathways highlights the role of miRNAs in the etiology and treatment resistance of gastric cancer

Life Sci. 2023 Jun 1:322:121667. doi: 10.1016/j.lfs.2023.121667. Epub 2023 Apr 4.

Abstract

Gastric cancer (GC) is 4th in incidence and mortality rates globally. Several genetic and epigenetic factors, including microRNAs (miRNAs), affect its initiation and progression. miRNAs are short chains of nucleic acids that can regulate several cellular processes by controlling their gene expression. So, dysregulation of miRNAs expressions is associated with GC initiation, progression, invasion capacity, apoptosis evasions, angiogenesis, promotion and EMT enhancement. Of important pathways in GC and controlled by miRNAs are Wnt/β-catenin signaling, HMGA2/mTOR/P-gp, PI3K/AKT/c-Myc, VEGFR and TGFb signaling. Hence, this review was conducted to review an updated view of the role of miRNAs in GC pathogenesis and their modulatory effects on responses to different GC treatment modalities.

Keywords: Gastric cancer (GC); Oncogenic miRNAs; Tumor suppressor (TS) miRNAs.

Publication types

  • Review

MeSH terms

  • Apoptosis / genetics
  • Cell Line, Tumor
  • Gene Expression Regulation, Neoplastic
  • Humans
  • MicroRNAs* / genetics
  • MicroRNAs* / metabolism
  • Phosphatidylinositol 3-Kinases / metabolism
  • Stomach Neoplasms* / pathology
  • Wnt Signaling Pathway / genetics

Substances

  • MicroRNAs
  • Phosphatidylinositol 3-Kinases